Chromium Satiety Randomized Trial: What the Evidence Says

Quick Answer

Chromium Satiety Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Studies have found that partial or complete MR can be an effective, extended strategy of medical nutrition therapy in T2DM management.However, the study's outcome is influenced by the duration of the intervention,the type of intervention,the type of MR,and frequency of the MR given,which play a role in the outcome of the study. [Che Wan Mansor Wan Ain Nadirah (2025); evidence level 2]
• Additionally, a study among pre-diabetic and overweight patients found that low GI MR increased hormone satiety and lowered hunger hormones after 2 months of intervention. [Che Wan Mansor Wan Ain Nadirah (2025); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For chromium satiety randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Che Wan Mansor Wan Ain Nadirah (2025). Evaluating diabetes-specific meal replacements for glycaemic control in overweight and obese patients with T2DM: a protocol for a randomised controlled trial. DOI: 10.1136/bmjopen-2025-099562. PMCID: PMC12517022. PMID: 41073120. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12517022/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.